文献速递鼻科小儿耳鼻咽喉

继发于鼻窦感染的眶周蜂窝织炎:英国多中心前瞻性研究

The management of periorbital cellulitis secondary to sinonasal infection: a multicenter prospective study in the United Kingdom.
PubMed 文献 · Int Forum Allergy Rhinol · 2020-04-13

英国8中心前瞻性研究纳入98例继发于上呼吸道感染/鼻窦炎的眶周蜂窝织炎住院患者,其中儿童72例、成人26例。结果显示头孢曲松联合甲硝唑从入院即用与最短住院时间(3.8天)及减少手术干预相关,早期鼻内减充血剂和激素使用也与手术需求减少相关。

要点

  • 头孢曲松联合甲硝唑从入院即用与最短住院时间3.8天相关
  • 早期鼻内减充血剂和激素使用与手术干预需求减少相关
  • 儿童手术干预率16.7%,成人19.2%,5例(4.9%)出现神经外科并发症

核心结论

  • 对于拭子和血培养常阴性的继发于鼻窦感染的眶周蜂窝织炎,本研究支持使用头孢曲松联合甲硝唑。
  • 鼻内减充血剂和皮质类固醇的使用与有或无眶周脓肿患者进展至手术的比例较小相关。

研究设计与样本

  • 英国8中心为期12个月的前瞻性研究,评估因继发于鼻窦感染的眶周蜂窝织炎需住院治疗的患者管理。
  • 共招募143例患者,排除40例,剩余103例中5例(4.9%)诊断为神经外科并发症,最终98例继发于上呼吸道感染/鼻窦炎的眶周蜂窝织炎患者纳入分析。
  • 98例中儿童72例,成人26例。

主要发现

  • 儿童72例中12例(16.7%)需要手术干预;成人26例中5例(19.2%)需要手术。
  • 最常用抗菌方案为静脉头孢曲松(联合或不联合甲硝唑)和阿莫西林克拉维酸。
  • 从入院即使用头孢曲松和甲硝唑与最短住院时间(3.8天)相关,相比单用头孢曲松(5.8天)或阿莫西林克拉维酸(4.5天)更短,且需要手术干预的患者数量减少。
  • 早期使用鼻内减充血剂和激素与手术干预需求减少相关。

关键数值与推荐

  • 头孢曲松联合甲硝唑从入院即用:住院时间3.8天。
  • 单用头孢曲松:住院时间5.8天。
  • 阿莫西林克拉维酸:住院时间4.5天。

临床怎么用

  • 对于继发于鼻窦感染的眶周蜂窝织炎住院患者,可考虑从入院即使用头孢曲松联合甲硝唑。
  • 可考虑早期使用鼻内减充血剂和皮质类固醇以减少手术干预需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periorbital cellulitis is a potential sight-threatening complication of sinusitis. The majority of patients improve with medical management. Previous studies have suggested significant variations in practice and lack of evidence regarding the optimal management of this condition. METHODS: A prospective study was conducted over a 12-month period at 8 centers in the United Kingdom assessing the management of patients requiring inpatient treatment for periorbital cellulitis secondary to sinonasal infections. RESULTS: A total of 143 patients were recruited, of whom 40 were excluded. Of the remaining 103 patients, 5 (4.9%) were diagnosed with neurosurgical complications. This resulted in 98 patients admitted with periorbital cellulitis secondary to an upper respiratory tract infection/sinusitis. A total of 72 were children, of whom 12 (16.7%) required surgical intervention; and of 26 adults, 5 (19.2%) required surgery: the most common antimicrobial regimes administered were intravenous ceftriaxone (with or without metronidazole), and co-amoxiclav. The use of both ceftriaxone and metronidazole from admission was associated with the shortest duration of inpatient stay (3.8 days) in comparison to ceftriaxone alone (5.8 days) or co-amoxiclav (4.5 days) and a reduction in number of patients requiring surgical intervention. There was also an association between the early use of intranasal decongestants and steroids and reduction in requirement for surgical intervention. CONCLUSION: For a condition where swab and blood cultures are often negative, this study supports the use of ceftriaxone in combination with metronidazole. The administration of intranasal decongestants and corticosteroids correlated with a smaller percentage of those progressing to surgery in those with and without periorbital abscesses.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Mahalingam S, Hone R, Lloyd G, et al. The management of periorbital cellulitis secondary to sinonasal infection: a multicenter prospective study in the United Kingdom. Int Forum Allergy Rhinol. 2020. PMID: 32282127. doi:10.1002/alr.22535

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。